1-4 of 4
Masaaki Kosaka
Close
Sort by
Journal Articles

Thalidomide-Induced Leukopenia in Japanese Patients with Refractory Multiple Myeloma.

Hirokazu Murakami, MD, PhD, Hiroshi Handa, MD, PhD, Masahiro Abe, MD, PhD, Shinsuke Iida, MD, PhD, Akihiro Ishii, MD, PhD, Takayuki Ishikawa, MD, PhD, Tadao Ishida, MD, PhD, Masatsugu Oota, MD, PhD, Shuji Ozaki, MD, PhD, Masaaki Kosaka, MD, PhD, Akira Sakai, MD, PhD, Morio Sawamura, MD, PhD, Kazuaki Shimizu, MD, PhD, Toshiyuki Takagi, MD, PhD, Hiroyuki Hata, MD, PhD, Takashi Fukuhara, MD, PhD, Hiroshi Fujii, MD, PhD, Akira Miyata, MD, PhD, Toshio Wakayama, MD, PhD, Kiyoshi Takatsuki, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5089.
https://doi.org/10.1182/blood.V108.11.5089.5089
Published: 2006
Journal Articles

Role for macrophage inflammatory protein (MIP)-1α and MIP-1β in the development of osteolytic lesions in multiple myeloma

Masahiro Abe, Kenji Hiura, Javier Wilde, Keiji Moriyama, Toshihiro Hashimoto, Shuji Ozaki, Shingo Wakatsuki, Masaaki Kosaka, Shinsuke Kido, Daisuke Inoue, Toshio Matsumoto
Journal: Blood
Blood (2002) 100 (6): 2195–2202.
https://doi.org/10.1182/blood.V100.6.2195
Published: 2002
Journal Articles

Humanized Anti-HM1.24 Antibody Mediates Myeloma Cell Cytotoxicity That Is Enhanced by Cytokine Stimulation of Effector Cells

Shuji Ozaki, Masaaki Kosaka, Yuji Wakahara, Yasuko Ozaki, Masayuki Tsuchiya, Yasuo Koishihara, Tetsuya Goto, Toshio Matsumoto
Journal: Blood
Blood (1999) 93 (11): 3922–3930.
https://doi.org/10.1182/blood.V93.11.3922
Published: 1999
Journal Articles

Immunotherapy of Multiple Myeloma With a Monoclonal Antibody Directed Against a Plasma Cell-Specific Antigen, HM1.24

Shuji Ozaki, Masaaki Kosaka, Shingo Wakatsuki, Masahiro Abe, Yasuo Koishihara, Toshio Matsumoto
Journal: Blood
Blood (1997) 90 (8): 3179–3186.
https://doi.org/10.1182/blood.V90.8.3179
Published: 1997